Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00448396 · ClinicalTrials.gov registry record · Phase 1
Evaluate the Effects of Patupilone on the Pharmacokinetics and Pharmacodynamics of Warfarin in Patients With Advanced Malignancies
A Phase 1 study, sponsored by Novartis Pharmaceuticals.
- Completed
- Registry status
- Phase 1
- Development phase
- 17
- Enrollment target
NCT00448396 is a Phase 1 study that has completed, run by Novartis Pharmaceuticals. The registered enrollment target is 17 participants.
The verdict
NCT00448396, a Phase 1 study, has completed, sponsored by Novartis Pharmaceuticals.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 17 participants
- Enrollment target
Study Summary
To evaluate the effects of patupilone on the pharmacokinetics of warfarin in patients with advanced malignancies.
Interventions
- DRUG Patupilone
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 17 participants |
| Start Date | 2007-03 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00448396
The ClinicalTrials.gov registry entry for NCT00448396 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 17 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Novartis Pharmaceuticals, which has 1,375 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Patupilone is the first listed.
NCT00448396 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00448396 about?
NCT00448396 is a clinical study titled "Evaluate the Effects of Patupilone on the Pharmacokinetics and Pharmacodynamics of Warfarin in Patients With Advanced Malignancies". To evaluate the effects of patupilone on the pharmacokinetics of warfarin in patients with advanced malignancies.
What is the current status of trial NCT00448396?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 17 participants. The study started on 2007-03.
What interventions are being tested in trial NCT00448396?
The interventions under investigation include: Patupilone (DRUG).
Who is sponsoring clinical trial NCT00448396?
This trial is sponsored by Novartis Pharmaceuticals, which has 1,375 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.